Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Huh

Showing results (341-350 of 365) with videos related to

Pageof 37
Sort By:
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 24, 2014
Risk factors for cytomegalovirus gastrointestinal diseases in adult patients with cancerJ-H Ko, K R Peck, W J Lee, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 21, 2007
Salvage of isolated vaginal recurrences in women with surgical stage I endometrial cancer: a multiinstitutional experienceW K Huh, J M Straughn, A Mariani, et al.
Molecular Biology of the Cell|March 6, 2015
Sec14-nodulin proteins and the patterning of phosphoinositide landmarks for developmental control of membrane morphogenesisRatna Ghosh, Marília K F de Campos, Jin Huang, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 2, 2020
Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group studyDana Chase, Helen Q Huang, Bradley J Monk, et al.
Gynecologic Oncology|January 3, 2009
Stage II uterine papillary serous carcinoma: Carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomesAmanda Nickles Fader, Christa Nagel, Allison E Axtell, et al.
Gynecologic Oncology|June 14, 2020
When to Operate, Hesitate and Reintegrate: Society of Gynecologic Oncology Surgical Considerations during the COVID-19 PandemicAmanda N Fader, Warner K Huh, Joshua Kesterson, et al.
Molecular Cancer Research : MCR|March 11, 2018
Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian CarcinomaRebecca C Arend, Angelina I Londoño, Allison M Montgomery, et al.
Gynecologic Oncology|July 4, 2021
Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysisKimberly Levinson, Anna L Beavis, Christopher Purdy, et al.
Gynecologic Oncology|August 21, 2025
A randomized pilot study of HPV16 L2E7E6 fusion protein vaccination site post-treatment for HPV16+ cervical cancerStéphanie Gaillard, Jade Alvarez, Tianbei Zhang, et al.
Journal of the National Cancer Institute|March 17, 2021
Quality of Life and Adverse Events: Prognostic Relationships in Long-Term Ovarian Cancer SurvivalLari Wenzel, Kathryn Osann, Chelsea McKinney, et al.
Pageof 37

Showing results (341-350 of 365) with videos related to

Sort By:
Pageof 37
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 24, 2014
Risk factors for cytomegalovirus gastrointestinal diseases in adult patients with cancerJ-H Ko, K R Peck, W J Lee, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 21, 2007
Salvage of isolated vaginal recurrences in women with surgical stage I endometrial cancer: a multiinstitutional experienceW K Huh, J M Straughn, A Mariani, et al.
Molecular Biology of the Cell|March 6, 2015
Sec14-nodulin proteins and the patterning of phosphoinositide landmarks for developmental control of membrane morphogenesisRatna Ghosh, Marília K F de Campos, Jin Huang, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 2, 2020
Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group studyDana Chase, Helen Q Huang, Bradley J Monk, et al.
Gynecologic Oncology|January 3, 2009
Stage II uterine papillary serous carcinoma: Carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomesAmanda Nickles Fader, Christa Nagel, Allison E Axtell, et al.
Gynecologic Oncology|June 14, 2020
When to Operate, Hesitate and Reintegrate: Society of Gynecologic Oncology Surgical Considerations during the COVID-19 PandemicAmanda N Fader, Warner K Huh, Joshua Kesterson, et al.
Molecular Cancer Research : MCR|March 11, 2018
Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian CarcinomaRebecca C Arend, Angelina I Londoño, Allison M Montgomery, et al.
Gynecologic Oncology|July 4, 2021
Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysisKimberly Levinson, Anna L Beavis, Christopher Purdy, et al.
Gynecologic Oncology|August 21, 2025
A randomized pilot study of HPV16 L2E7E6 fusion protein vaccination site post-treatment for HPV16+ cervical cancerStéphanie Gaillard, Jade Alvarez, Tianbei Zhang, et al.
Journal of the National Cancer Institute|March 17, 2021
Quality of Life and Adverse Events: Prognostic Relationships in Long-Term Ovarian Cancer SurvivalLari Wenzel, Kathryn Osann, Chelsea McKinney, et al.
Pageof 37